Cloxacillin as Prevention of Double Lumen Infection in Hemodialysis Patients
Not Applicable
Completed
- Conditions
- Double Lumen InfectionHemodialysis
- Interventions
- Registration Number
- NCT00885300
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
The purpose of this study is to investigate whether cloxacillin lock is effective in prevention of double lumen infection.
- Detailed Description
Double lumen infection is one of the causes of morbidity and mortality in hemodialysis patients. Many strategies used to prevent it and one of them is antibiotic lock. Thus we select chronic hemodialysis patients and divided them into 2 groups. One group received cloxacillin and heparin as catheter lock and the second group received only heparin lock.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- hemodialysis for 3 months
- at least 2 time dialysis/week
Exclusion Criteria
- active infection
- acute renal failure
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 1 cloxacillin cloxacillin 100 mg/ml + heparin 1000iu/ml as catheter lock at the end of hemodialysis 1 heparin cloxacillin 100 mg/ml + heparin 1000iu/ml as catheter lock at the end of hemodialysis 2 heparin heparin 1000iu/ml as catheter lock at the end of hemodialysis
- Primary Outcome Measures
Name Time Method catheter infection 6 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Shiraz University Hemodialysis Center
🇮🇷Shiraz, Fars, Iran, Islamic Republic of